Mid Year Newsletter 2015

Mid Year Newsletter 2015

Welcome to our latest newsletter, designed to keep you up to date with news and information from PaPaS. We have had another busy start to the year, with welcoming a new member of staff, attending international conferences, and continuing to publish high quality protocols, reviews and updates. We’re working hard on continuing to improve efficiencies in the editorial process, updating guidance documentation for our contributors, and monitoring our timelines to publication. We are building partnerships and improving engagement on social media, and we are collaborating on prioritisation projects in areas such as chronic pain, paediatric palliative care and end of life care. We are also planning an exciting event in 2016. Read on to find out more!

Thank you to all of our valued contributors, Anna Hobson

Managing Editor W: papas.cochrane.org  E: anna.hobson@ndcn.ox.ac.uk    T:+44 (0)1865 225762

Staff update

We are delighted to  introduce Tess Cooper to the PaPaS team. Tess is  working with us as a Systematic Reviewer, a post funded by our NIHR programme grant. 


2015 to date (at 14 August)

  • 19 new reviews
  • 18 protocols
  • 17 updates

Social Media

We now have an amazing 2920 followers of #painevidence. Help us make it to 3000! Share our latest news and reviews: follow us @CochranePaPaS.

Useful hashtags and people, that may be of interest to our authors:

  • #PaPaStheme: we have a different theme every month, follow for reviews, blogs, articles and more.
  • @UKCochraneCentr: home of the new #blogshot, accessible infographic summaries of the latest Cochrane reviews.


Conflicts of Interest policy: the policy relating to conflicts of interest has been updated, see here. All authors are now advised to list their declaration of interest individually.

New automated 6 month de-registration of titles: titles will be de-registered if a first draft protocol is not received  6 months after title registration (extenuating circumstances may apply).

Common screening errors: are being added to the guidance documentation. The documentation will be available from our Resources page here.

Implications for research: new suggested  subheadings for ‘Implications for research’ are being added to the guidance documentation. The documentation will be available from our Resources page here.

Covidence: new software available for authors. See here. “Covidence improves healthcare evidence synthesis by improving the efficiency and experience of creating and maintaining systematic reviews”.

New website

Following our recent rebrand, we would like to introduce our new and updated website.  Here you will find information about us, our reviews, our editorial procedures (including lots of useful information for authors and peer reviewers), PaPaS and Cochrane news, plus the Palliative Care Database, as well as lots of other really useful information. Take a look and tell us what you think!

NIHR Programme Grant

Addressing the unmet need of chronic pain: providing the evidence for treatments of pain

In 2014, we were awarded a UK National Institute for Health Research (NIHR) Systematic Reviews Programme Grant to undertake systematic reviews and appraisal of the evidence for pharmacological and non-pharmacological interventions in chronic pain.

The grant focuses on three areas of significant unmet need in the UK population:

1. Pain in children

2. Chronic non-cancer pain (neuropathic)

3. Cancer pain (neuropathic)

For more information, see here.

2014 Impact Factor

The 2014 Impact Factor for PaPaS is 7 (75 publications cited 525 times). A review published by PaPaS in 2012 or 2013 was cited, on average, 7 times in 2014.

Recent and upcoming meetings

We have been to:

We are going to:

European Pain Federation Congress, 2-5 September, Vienna, Austria


Cochrane Colloquium, 3-7 October, Vienna, Austria


Don’t forget to tell us about your meetings and conferences in 2015.

Email Anna Hobson at anna.hobson@ndcn.ox.ac.uk or Tweet us @CochranePaPaS


January, Issue 1

Palliative pharmacological sedation for terminally ill adults (Update)

NIHR Cochrane Incentive Scheme 2013, UK; Award Reference Number: 14/175/01. Priority arose from development of NICE guidance for end of life care; completed by deadline of 31 Dec 2014.

March, Issue 3

As required versus fixed schedule analgesic administration for postoperative pain in children (New review)

This review was commissioned by the National Institute for Health Research (NIHR) in the UK in response to a National Health Service (NHS) 'decision problem' regarding outpatient management of postoperative pain in children. National Institute for Health Research (NIHR), UK; NIHR Directly Commissioned Cochrane Incentive Scheme, Award Reference Number: 13/180/13.

April, Issue 4

Corticosteroids for the management of cancer-related pain in adults (New review)

Cochrane podcast (not yet published)

Feverfew for preventing migraine (Update)

Cochrane podcast (not yet published)

May, Issue 5

Pharmacological treatments for fatigue associated with palliative care (Update)

Cochrane featured review (see here); Cochrane podcast (not yet published)

Sweet tasting solutions for reduction of needle-related procedural pain in children aged one to 16 years (Update)

Cochrane podcast (not yet published)

June, Issue 6

Topical NSAIDs for acute musculoskeletal pain in adults (Update)

Cochrane featured review (see here); blogshot (see here) and blog on Evidently Cochrane (see here)

23rd Cochrane Colloquium 2015

This year’s 23rd Cochrane Colloquium will be held in Vienna, Austria with the theme Filtering the Information Overload for Better Decisions.

Registration open until 9th September.

There has been a record number of abstract (708) and workshop (164) submissions.

We will be at the Meet the Groups  session. See here. Come and say hello!

Birthday Party

In 2016, PaPaS will celebrate 18 years since registering as an official Cochrane review group. We would like you to join us in this celebration. We are planning a day of events on Thursday 21st July 2016 in Oxford. More details will follow, but please be sure to save the date in your diaries.